ICU Medical Commits to Acquire Smith for ~$2.35B

 ICU Medical Commits to Acquire Smith for ~$2.35B

ICU Medical, Acquire, Smith, ~$2.35B


  • Smiths to receive 2.5M at closing in cash and stock which is currently valued at ~$500M, $1.85B in cash along with liabilities & is eligible for up to $100M in milestones. The transaction is expected to close in H1’22
  • The acquisition combines Smiths’ business includes syringes, ambulatory infusion devices, vascular access & vital care products with ICU Medical’s existing businesses to create a leading infusion therapy company with a stronger global reach
  • The companies have entered into an option agreement in which Smiths has the right to acquire ICU Medical by entering into a binding share purchase agreement. Additionally, Smith will retain ~ 10% of ICU Medical

Click here to read full press release/ article | Ref: Globe Newswire | Image: PharmaLive

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on

Related post